This clinical trial examines how the study compound is processed and eliminated by the body and how well it is tolerated when it is used by healthy participants.
From 18 hours before dosing until 36 hours after, your heart will be monitored constantly (i.e. for 54 hours). For this purpose, you will receive pads (electrodes) on your chest that are attached to a device. As long as you are connected to this device, you cannot shower and must behave as calmly as possible. Occasionally you will have to lie still for 15 minutes without moving, talking or sleeping. Also, you cannot then listen to music, watch TV or use a laptop or phone.
The effects of the study compound are compared with the effects of a placebo (compound without active substance). Whether you receive the study compound or placebo is determined by lot.
You can only participate in one group of this trial.
Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können.